3 recruiting, 1 active not recruiting, 1 not yet recruiting, 1 unknown. 2 Phase 2, 2 Phase 4, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
| Phase 4 | 2 | Active not recruiting 1, Not yet recruiting 1 |
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Crisugabalin: new trials by email Literature Review of Crisugabalin trials Research Report on Crisugabalin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial Crisugabalin, Placebo+Crisugabalin - Neuromyelitis Optica Spectrum Disorders (NMOSD), Neuropathic Pain | Phase 4 | Not yet recruiting | Tang-Du Hospital | 110 | 2026-06-15 | 2026-07-13 |
| EFficacy and safEty of cRisugabalin on nocipLastic paIn in Patients With Parkinson's Disease (RELIEF-PD): a Multicentre, Double-blind, Randomised Controlled Trial Crisugabalin, Placebo - PARKINSON DISEASE (Disorder) | Phase 4 | Active not recruiting | Guangdong Provincial People's Hospital | 166 | 2026-03-13 | 2026-09-14 |
| Novel Calcium Channel Modulators in RLS and Variants: Efficacy & Safety Crisugabalin - Restless Leg Syndrome (RLS), Variant Restless Legs Syndrome | Phase 1 | Recruiting | Beijing Friendship Hospital | 20 | 2026-03-10 | 2026-03-06 |
| The Efficacy and Safety of Pregabalin and Crisugabalin in Patients With Fibromyalgia Pregabalin, Crisugabalin - Fibromyalgia, Pregabalin | Not applicable | Recruiting | Beijing Tiantan Hospital | 1116 | 2025-09-30 | 2026-02-11 |
| Crisugabalin for Radiotherapy-Related Neuropathic Pain Crisugabalin, Pregabalin - Neuropathic Pain | Phase 2 | Recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 172 | 2025-05-07 | 2025-05-18 |
| Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain Who Had an Inadequate Response to Pregabalin HSK16149 20mg BID, Pregabalin 150mg BID - Diabetic Peripheral Neuropathic Pain | Phase 2 | Unknown | Haisco Pharmaceutical Group Co., Ltd. | 90 | 2024-04-19 | 2024-07-08 |
Neuralgia (2) · Fibromyalgia (1) · Head and Neck Neoplasms (1) · Neuromyelitis Optica (1) · Nociceptive Pain (1) · Pain (1) · Parkinson Disease (1) · Restless Legs Syndrome (1)
Beijing Friendship Hospital (1) · Beijing Tiantan Hospital (1) · Guangdong Provincial People's Hospital (1) · Haisco Pharmaceutical Group Co., Ltd. (1) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1) · Tang-Du Hospital (1)
China (6)
Jun Guo (1) · Yamei Tang, M.D., PhD (1)